ZA832927B - Benzoazacycloalkyl-spiro-imidazolidines,their preparation and compositions containing them - Google Patents

Benzoazacycloalkyl-spiro-imidazolidines,their preparation and compositions containing them

Info

Publication number
ZA832927B
ZA832927B ZA832927A ZA832927A ZA832927B ZA 832927 B ZA832927 B ZA 832927B ZA 832927 A ZA832927 A ZA 832927A ZA 832927 A ZA832927 A ZA 832927A ZA 832927 B ZA832927 B ZA 832927B
Authority
ZA
South Africa
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
preparation
compositions containing
Prior art date
Application number
ZA832927A
Other languages
English (en)
Inventor
Charles Malen
Jean Louis Peglion
Jacques Duhault
Michelle Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA832927B publication Critical patent/ZA832927B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA832927A 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines,their preparation and compositions containing them ZA832927B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ZA832927B true ZA832927B (en) 1984-06-27

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA832927A ZA832927B (en) 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines,their preparation and compositions containing them

Country Status (22)

Country Link
JP (1) JPS5910584A (fr)
KR (1) KR840004428A (fr)
AT (1) ATA125383A (fr)
AU (1) AU1395383A (fr)
BE (1) BE896572A (fr)
DD (1) DD209833A5 (fr)
DE (1) DE3315106A1 (fr)
DK (1) DK183583A (fr)
ES (1) ES521895A0 (fr)
FR (1) FR2525603A1 (fr)
GB (1) GB2133401B (fr)
GR (1) GR78481B (fr)
IL (1) IL68497A0 (fr)
IT (1) IT1167123B (fr)
LU (1) LU84770A1 (fr)
MA (1) MA19783A1 (fr)
NL (1) NL8301476A (fr)
NO (1) NO831473L (fr)
OA (1) OA07412A (fr)
PT (1) PT76595B (fr)
SE (1) SE8302347L (fr)
ZA (1) ZA832927B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
HUE028976T2 (en) 2003-06-17 2017-02-28 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
CN1805939B (zh) 2003-06-17 2010-10-13 艾尼纳制药公司 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物
DK1838677T3 (da) 2004-12-21 2010-01-11 Arena Pharm Inc Krystallinske former af (R)-8-chlor-1.methyl-2,3,4,5-tetrahydro-1H-3-benzazepinhydrochlorid
SI1833473T1 (sl) 2004-12-23 2010-01-29 Arena Pharm Inc Sestavki modulatorjev 5HT2C receptorjev in postopki uporabe
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ, インコーポレイテッド 8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
SG177128A1 (en) 2006-12-05 2012-01-30 Arena Pharm Inc Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
EP2443080A2 (fr) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Procédés pour la préparation d'agonistes du récepteur 5-ht<sb>2c</sb>
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
CN103347523A (zh) 2010-09-01 2013-10-09 艾尼纳制药公司 向具有肾损伤的个体给药氯卡色林
CA2808904A1 (fr) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Sels non hygroscopiques d'agonistes de 5-ht2c
EP2611782A1 (fr) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Sels de lorcasérine dotés d'acides optiquement actifs
EP3485878A1 (fr) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Formes posologiques à libération modifiée d'agonistes de 5-ht2c utiles pour la gestion du poids
MY181736A (en) 2012-10-09 2021-01-05 Arena Pharm Inc Method of weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
NO831473L (no) 1983-10-28
KR840004428A (ko) 1984-10-15
DK183583A (da) 1983-10-28
SE8302347L (sv) 1983-10-28
ATA125383A (de) 1986-05-15
FR2525603B1 (fr) 1984-09-14
GB8311508D0 (en) 1983-06-02
ES8405796A1 (es) 1984-06-16
OA07412A (fr) 1984-11-30
AU1395383A (en) 1983-11-03
FR2525603A1 (fr) 1983-10-28
JPS5910584A (ja) 1984-01-20
BE896572A (fr) 1983-10-26
ES521895A0 (es) 1984-06-16
PT76595B (fr) 1986-01-21
IT8348155A0 (it) 1983-04-26
DD209833A5 (de) 1984-05-23
GB2133401B (en) 1985-10-23
IL68497A0 (en) 1983-07-31
IT1167123B (it) 1987-05-13
PT76595A (fr) 1983-05-01
SE8302347D0 (sv) 1983-04-26
GR78481B (fr) 1984-09-27
LU84770A1 (fr) 1984-11-28
DK183583D0 (da) 1983-04-26
DE3315106A1 (de) 1983-11-03
NL8301476A (nl) 1983-11-16
MA19783A1 (fr) 1983-12-31
GB2133401A (en) 1984-07-25

Similar Documents

Publication Publication Date Title
DE3369517D1 (en) Didehydromilbemycin derivatives, their preparation and compositions containing them
IL70422A0 (en) 1-azolyl-2-aryl-3-fluoroalkan-2-ols,their preparation and microbicidal compositions containing them
IL67826A0 (en) Pyrazolooxazines,pyrazolothiazines and pyrazoloquinolines,their preparation and pharmaceutical compositions containing them
DE3468030D1 (en) 13-alpha-alkyl gonanes, their preparation and pharmaceutical compositions containing them
IL63940A0 (en) Substituted imino-diacids,their preparation and pharmaceutical compositions containing them
IL70360A0 (en) Isoxazoles,their preparation and antiviral compositions containing them
IL73951A0 (en) 2-phenyl-imidazoles,their preparation and pharmaceutical compositions containing them
IL71475A0 (en) N-aryl-alpha-amino-carboxamides,their preparation and pharmaceutical compositions containing them
IL64444A0 (en) 8-arylalkyl-3-phenyl-3-nortropanols,their preparation and pharmaceutical compositions containing them
ZA832927B (en) Benzoazacycloalkyl-spiro-imidazolidines,their preparation and compositions containing them
IL71481A0 (en) Substituted indeno-pyridazinones,their preparation and pharmaceutical compositions containing them
IL69796A (en) Phenylcycloalkylalkane derivatives,their preparation and arthropodicidal compositions containing them
ZW16583A1 (en) Milbemycind derivatives their preparation and compositions containing them
ZA816844B (en) Substituted iminodiacids,their preparation and pharmaceutical compositions containing them
IL68586A0 (en) 4-aryl-4-piperidinecarbinols,their preparation and pharmaceutical compositions containing them
IL68699A0 (en) 3-phenoxy-1-azetidinecarboxamides,their preparation and pharmaceutical compositions containing them
IL71419A0 (en) Phenylaminobenzenealkanols,their preparation and pharmaceutical compositions containing them
IL72123A0 (en) Substituted phenylalkyl-piperazinyl-and homopiperazinyl-propyl-ureas and-thioureas,their preparation and pharmaceutical compositions containing them
IL72307A0 (en) Pyridinyl-2-pyrimidinamines,their preparation and pharmaceutical compositions containing them
IL62495A0 (en) Pyrimidyl-quinazolines,their preparation and pharmaceutical compositions containing them
IL70158A (en) Tetrahydronaphthalene-carboxamides,their preparation and pharmaceutical compositions comprising them
IL71110A0 (en) Azolylmethylcycloalkanes,their preparation and pharmaceutical compositions containing them
IL71661A0 (en) 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them
IL72831A0 (en) 2-aminomethyl-penem compounds,their preparation and pharmaceutical compositions containing them
IL62606A0 (en) Pyrrolylpiperidines,their preparation and pharmaceutical compositions containing them